Effects of a Diagnosis-Related Group Payment Reform on Length and Costs of Hospitalization in Sichuan, China: A Synthetic Control Study
Yaqing Liu,Sixian Du,Jianbo Cao,Haoran Niu,Feng Jiang,Liwen Gong
DOI: https://doi.org/10.2147/rmhp.s463276
2024-06-15
Risk Management and Healthcare Policy
Abstract:Yaqing Liu, 1, 2 Sixian Du, 1 Jianbo Cao, 1 Haoran Niu, 1 Feng Jiang, 1 Liwen Gong 1 1 School of Medicine and Health Management, Huazhong University of Science and Technology, Wuhan, Hubei, People's Republic of China; 2 Huazhong University of Science and Technology's Double First-Class Discipline Platform in Humanities (Research Center for Hospital High-Quality Development), Wuhan, Hubei, People's Republic of China Correspondence: Sixian Du, School of Medicine and Health Management, Huazhong University of Science and Technology, 5th Floor, No. 13 Hangkong Road, Qiaokou District, Wuhan, Hubei, 430030, People's Republic of China, Tel +8618271878646, Email Background: Diagnosis-related group (DRG) payment policies are increasingly recognized as crucial instruments for addressing health care overprovision and escalating health care costs. The synthetic control method (SCM) has emerged as a robust tool for evaluating the efficacy of health policies worldwide. Methods: This study focused on Panzhihua city in Sichuan Province, a pilot city for DRG payment reform implementation, serving as the treatment group. In contrast, 20 nonpilot cities within the province were utilized as potential control units. A counterfactual control group was constructed to evaluate the changes in average inpatient stay duration and health care organization costs following the DRG payment reform initiated in 2018. Results: Focusing on Panzhihua, Sichuan Province, the analysis reveals that following the reform in March 2018, the average length of hospital stay in Panzhihua decreased by 1.35 days during 2019– 2021. Additionally, the average cost per hospitalization dropped by 855.48 RMB, the average cost of medication per hospitalization decreased by 68.51 RMB, and the average cost of diagnostic and therapeutic procedures per hospitalization declined by 136.37 RMB. While global evidence backs DRGs for efficiency and cost reduction, challenges persist in addressing emerging issues like new conditions. Conclusion: Since its introduction in 2018, the DRG payment reform in Sichuan Province has effectively reduced both the duration of hospital stays and the operational costs of health care facilities. However, potential drawbacks include compromised service quality and an elevated risk of patient readmission, indicating a need for further refinement in the implementation of DRG payment reforms in China. Keywords: synthetic control method, health policy evaluation, diagnosis-related grouping, DRG, average hospitalization days, average hospital costs, China In 2020, global health spending soared to an unprecedented $9 trillion, equivalent to approximately 11% of the world's GDP, 1 driven significantly by the COVID-19 pandemic. Hospitalization, accounting for 40% of total government and social health care expenditures on average, 2 has become a central focus of health care policy reforms globally. In China, health expenditures reached RMB 8,532.749 billion in 2022, or 7.0% of GDP. 3,4 The cost per hospital stay was 11,673.70 yuan, with an average duration of 9.2 days. 5 These factors have significantly contributed to the rising total health expenditures. In response, the Chinese government has prioritized reforming hospital payment methods to reduce inpatient service costs and enhance hospital operational efficiency. These reforms aim to address the financial pressures from prolonged hospital stays and high hospitalization costs, which heavily impact overall health spending. By implementing more efficient payment systems and cost-control measures, the government seeks to curb rising health care costs, ensuring better resource allocation and sustainability within the health sector. This strategy not only aims to reduce the economic burden on the government and society but also to improve the quality and accessibility of health care for the population. 6 Historically, the fee-for-service (FFS) model has dominated hospital financing globally since the 1980s. This system incentivizes health care organizations to provide numerous itemized services, inadvertently increasing overall health care expenditures. In response, the diagnosis-related group (DRG) methodology was developed by Fetter in the United States in 1983 7 DRGs establish costs and categorize patients based on their diagnosis and additional characteristics such as age, gender, severity, and complications. Under the DRG system, 8,9 health care providers receive predetermined compensation per case, independent of actual treatment costs, aiming to streamline expenses by reducing hospitalization durations and costs 7,10 . The DRG payment polic -Abstract Truncated-
health care sciences & services,health policy & services